EPM speaks to Chris Ross, head of Life Science Integrated Supply Chain Operations at Merck to discuss the company's response to Covid-19 and the challenges in developing and supplying vaccines.
Q&A
What’s Merck doing to support Covid-19 efforts?
We’re supporting the global scientific community in the response to Covid-19 by providing the necessary products and services for virus research and detection along with the development of therapies and vaccines. Each of these areas is critical in slowing the progression of Covid-19, and ultimately, treating and protecting people in the future. Overall, we offer approximately 200 products for scientists working on Covid-19 research and potential vaccines.
We continue to support many of our customers working on Covid-19 projects, including: